Page 2478 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 151 Hematologic Changes in Pregnancy 2214.e1

and erythrocyte protoporphyrin determinations. Br J Obstet Gynaecol
REFERENCES 90:101, 1983.
26. Hiss RG: Evaluation of the anemic patient. In Laros RK, editor: Blood
1. World Health Organization: The prevalence of anaemia in women: a disorders in pregnancy, Philadelphia, 1986, Lea & Febiger, p 1.
tabulation of available information, ed 2, Geneva, 1992, World Health 27. Rothman D: Folic acid in pregnancy. Am J Obstet Gynecol 108:149,
Organization. 1970.
2. Crowley JP: Coagulopathy bleeding in the parturient patient: recent 28. Chanarin I, MacGibbon BM, O’Sullivan WJ, et al: Folic acid deficiency
information has helped in the identification of individuals at special in pregnancy—the pathogenesis of megaloblastic anemia of pregnancy.
risk. R I Med J 72:135, 1989. Lancet 2:634, 1959.
3. Hytten F: Blood volume changes in normal pregnancy. Clin Haematol 29. Chanarin I: Folate and cobalamin. Clin Haematol 14:729, 1985.
14:601, 1985. 30. Rust OA, Perry KG: Pregnancy complicated by sickle hemoglobinopa-
4. Centers for Disease Control and Prevention (CDC): CDC criteria thy. Clin Obstet Gynecol 38:472, 1995.
for anemia in children and childbearing-aged women. MMWR Morb 31. Thurman AR, Steed LL, Hulsey T, et al: Bacteriuria in pregnant women
Mortal Wkly Rep 38:400, 1989. with sickle cell trait. Am J Obstet Gynecol 194:1366, 2006.
5. Garn SM, Ridella SA, Petzold AS, et al: Maternal hematologic levels 32. Koshy M, Burd L: Management of pregnancy in sickle cell syndromes.
and pregnancy outcomes. Semin Perinatol 5:155, 1981. Hematol Oncol Clin North Am 5:585, 1991.
6. Singh K, Fong YF, Arulkumaran S: Anaemia in pregnancy—a cross- 33. Sun PM, Wilburn W, Raynor BD, et al: Sickle cell disease in pregnancy:
sectional study in Singapore. Eur J Clin Nutr 52:65, 1998. twenty years of experience at Grady Memorial Hospital, Atlanta,
7. Klebanoff MA, Shiono PH, Selby JV, et al: Anemia and spontaneous Georgia. Am J Obstet Gynecol 184:1127, 2001.
preterm birth. Am J Obstet Gynecol 164:59, 1991. 34. Diav-Citrin O, Hunnisett L, Sher GD, et al: Hydroxyurea use during
8. Lu ZM, Goldenberg RL, Oliver SP, et al: The relationship between pregnancy: a case report in sickle cell disease and review of the literature.
maternal hematocrit and pregnancy outcome. Obstet Gynecol 77:190, Am J Hematol 60:148, 1999.
1991. 35. Morrison JC, Schneider JM, Whybrew WD, et al: Prophylactic transfu-
9. Murphy JF, O’Riordan J, Newcombe RG, et al: Relation of haemoglo- sion in patients with sickle hemoglobinopathies. Obstet Gynecol 62:419,
bin levels in first and second trimesters to outcome of pregnancy. Lancet 1983.
1:992, 1986. 36. Koshy M, Burd L, Wallace D, et al: Prophylactic red-cell transfusions
10. Lieberman E, Ryan KJ, Monson RR, et al: Association of maternal in pregnant patients with sickle cell disease: a randomized cooperative
hematocrit with premature labor. Am J Obstet Gynecol 159:107, 1988. study. N Engl J Med 319:1447, 1988.
11. Scholl TO, Hediger ML: Anemia and iron-deficiency anemia: compila- 37. Kilpatrick SJ, Laros RK: Thalassemia in pregnancy. Clin Obstet Gynecol
tion of data on pregnancy outcome. Am J Clin Nutr 59(2 Suppl):492S, 38:485, 1995.
1994. 38. Alger LS, Golbus MS, Laros RK: Thalassemia and pregnancy. Am J
12. Scholl TO, Hediger ML, Fischer RL, et al: Anemia vs iron deficiency: Obstet Gynecol 134:662, 1979.
increased risk of preterm delivery in a prospective study. Am J Clin Nutr 39. White JM, Richards R, Byrne M, et al: Thalassemia trait and pregnancy.
55:985, 1992. J Clin Pathol 38:810, 1985.
13. Zhou LM, Yang WW, Hua JZ, et al: Relation of hemoglobin measured 40. Fleming AF: Maternal anemia and fetal outcome in pregnancies
at different times in pregnancy to preterm birth and low birth weight complicated by thalassemia minor and “stomatocytosis”. Am J Obstet
in Shanghai, China. Am J Epidemiol 148:998, 1998. Gynecol 116:309, 1973.
14. Centers for Disease Control and Prevention (CDC): Recommendations 41. Singer ST, Vichinsky EP: Deferoxamine treatment during pregnancy:
to prevent and control iron deficiency in the United States. MMWR is it harmful? Am J Hematol 60:24, 1999.
Recomm Rep 47(RR-3):1, 1998. 42. Agre P: Hereditary spherocytosis. JAMA 262:2887, 1989.
15. Institute of Medicine: Nutrition services in perinatal care, Washington, 43. Pajor A, Lehoczky D, Szakacs Z: Pregnancy and hereditary spherocy-
DC, 1992, National Academy Press. tosis. Arch Gynecol Obstet 253:37, 1993.
16. Galloway R, McGuire J: Determinants of compliance with iron supple- 44. Ho-Yen DO: Hereditary spherocytosis presenting in pregnancy. Acta
mentation: supplies, side effects, or psychology? Soc Sci Med 39:381, Haematol 72:29, 1984.
1994. 45. Delamore IW, Richmond J, Davies SH: Megaloblastic anaemia in
17. Chanarin I, Rothman D: Further observations on the relation between congenital spherocytosis. Br Med J 1:543, 1961.
iron and folate status in pregnancy. Br Med J 2:81, 1971. 46. Maberry MC, Mason RA, Cunningham FG, et al: Pregnancy compli-
18. Bothwell TH: Overview and mechanisms of iron regulation. Nutr Rev cated by hereditary spherocytosis. Obstet Gynecol 79:735, 1992.
53:237, 1995. 47. Perkins RP: The significance of glucose-6-phosphate dehydrogenase
19. Casanueva E, Viteri FE, Mares-Galindo M, et al: Weekly iron as a safe deficiency in pregnancy. Am J Obstet Gynecol 125:215, 1975.
alternative to daily supplementation for nonanemic pregnant women. 48. Perkins RP: Hydrops fetalis and stillbirth in a male glucose-6-phosphate
Arch Med Res 12:674, 2006. dehydrogenase-deficient fetus possible due to maternal ingestion of
20. Al RA, Unlubilgin E, Kandamir O, et al: Intravenous versus oral sulfisoxazole. Am J Obstet Gynecol 111:379, 1971.
iron for treatment of anemia in pregnancy: a randomized trial. Obstet 49. Spencer JA: Paroxysmal nocturnal haemoglobinuria in pregnancy: case
Gynecol 106:1335, 2005. report. Br J Obstet Gynaecol 87:246, 1980.
21. Cogswell ME, Parvanta I, Ickes L, et al: Iron supplementation during 50. Ray JG, Burows RF, Ginsberg JS, et al: Paroxysmal nocturnal hemoglo-
pregnancy, anemia, and birth rate: a randomized trial. Am J Clin Nutr binuria and the risk of venous thrombosis: review and recommendations
78:773, 2003. for management of the pregnant and nonpregnant patient. Haemostasis
22. Perry GS, Yip R, Zyrkowski C: Nutritional risk factors among low- 30:103, 2000.
income pregnant US women: the Centers for Disease Control and 51. Parker C, Omine M, Richards S, et al: Diagnosis and management of
Prevention (CDC) Pregnancy Nutrition Surveillance System, 1979 paroxysmal nocturnal hemoglobinuria. Blood 106:3699, 2005.
through 1993. Semin Perinatol 19:211, 1995. 52. Hillmen P, Young NS, Shubert J, et al: The complement inhibitor
23. Council on Foods and Nutrition Committee on Iron Deficiency: Iron eculizimab in paroxysmal nocturnal hemoglobinuria. N Engl J Med
deficiency in the United States. JAMA 203:119, 1968. 355:1233, 2006.
24. Milman N, Agger AI, Nielson OJ: Iron status markers and serum 53. Sacks DA, Platt LD, Johnson CS: Autoimmune hemolytic disease
erythropoietin in 120 mothers and newborn infants: Effect of iron during pregnancy. Am J Obstet Gynecol 60:742, 1982.
supplementation and normal pregnancy. Acta Obstet Gynecol Scand 54. Kumar R, Advani AR, Sharan J, et al: Pregnancy induced hemolytic
73:200, 1994. anemia: an unexplained entity. Ann Hematol 80:623, 2001.
25. Romslo I, Haram K, Sagen N, et al: Iron requirement in normal 55. Burrows R, Kelton J: Thrombocytopenia at delivery. Am J Obstet
pregnancy as assessed by serum ferritin, serum transferring saturation, Gynecol 162:731, 1990.